{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:42:38Z","timestamp":1771011758278,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Art of the Brain Foundation"},{"name":"Henry E. Singleton Brain Cancer Research Program"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.yexmp.2017.06.006","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T07:33:00Z","timestamp":1498548780000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats"],"prefix":"10.1016","volume":"103","author":[{"given":"Masoud","family":"Movassaghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Shabihkhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed A.","family":"Hojat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrance K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyuseok","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M.","family":"Lucey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Mareninov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise W.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy S.","family":"Tashjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shino","family":"Magaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Perez-Rosendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5176-5615","authenticated-orcid":false,"given":"Isaac","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Khanlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry V.","family":"Vinters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-0052","authenticated-orcid":false,"given":"Linda M.","family":"Liau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phioanh L.","family":"Nghiemphu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy F.","family":"Cloughesy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yexmp.2017.06.006_bb0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cancergen.2013.11.002","article-title":"Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches","volume":"206","author":"Abel","year":"2013","journal-title":"Cancer Genet."},{"issue":"1","key":"10.1016\/j.yexmp.2017.06.006_bb0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-3639.2009.00352.x","article-title":"Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors","volume":"20","author":"Capper","year":"2010","journal-title":"Brain Pathol."},{"issue":"7","key":"10.1016\/j.yexmp.2017.06.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127353","article-title":"Robustness of next generation sequencing on older formalin-fixed paraffin-embedded tissue","volume":"10","author":"Carrick","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.yexmp.2017.06.006_bb0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-013-0345-4","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"13","author":"Cohen","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"Suppl. 5","key":"10.1016\/j.yexmp.2017.06.006_bb0025","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009","volume":"14","author":"Dolecek","year":"2012","journal-title":"Neuro-Oncology"},{"issue":"4","key":"10.1016\/j.yexmp.2017.06.006_bb0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pbc.20803","article-title":"MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma","volume":"48","author":"Donson","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.yexmp.2017.06.006_bb0035","author":"FoundationOne"},{"issue":"11","key":"10.1016\/j.yexmp.2017.06.006_bb0040","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.yexmp.2017.06.006_bb0045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1593\/neo.10688","article-title":"Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance","volume":"12","author":"Hatanpaa","year":"2010","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.yexmp.2017.06.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098187","article-title":"Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue","volume":"9","author":"Hedegaard","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yexmp.2017.06.006_bb0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/019262330002800121","article-title":"Phenotype vs genotype in the evolution of astrocytic brain tumors","volume":"28","author":"Kleihues","year":"2000","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.yexmp.2017.06.006_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/neuonc\/1.1.44","article-title":"Primary and secondary glioblastomas: from concept to clinical diagnosis","volume":"1","author":"Kleihues","year":"1999","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10.1016\/j.yexmp.2017.06.006_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11060-011-0738-7","article-title":"Improved survival time trends for glioblastoma using the SEER 17 population-based registries","volume":"107","author":"Koshy","year":"2012","journal-title":"J. Neuro-Oncol."},{"issue":"9","key":"10.1016\/j.yexmp.2017.06.006_bb0070","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/0008-5472.CAN-08-3913","article-title":"Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas","volume":"69","author":"Kuo","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.yexmp.2017.06.006_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.yexmp.2017.06.006_bb0080","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"15","key":"10.1016\/j.yexmp.2017.06.006_bb0085","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1200\/JCO.2012.46.5948","article-title":"Existing and emerging technologies for tumor genomic profiling","volume":"31","author":"MacConaill","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.yexmp.2017.06.006_bb0090","first-page":"177","article-title":"Next-generation sequencing for cancer diagnostics: a practical perspective","volume":"32","author":"Meldrum","year":"2011","journal-title":"Clin. Biochem. Rev."},{"issue":"1","key":"10.1016\/j.yexmp.2017.06.006_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1750-3639.2003.tb00006.x","article-title":"Targeted molecular therapy of GBM","volume":"13","author":"Mischel","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.yexmp.2017.06.006_bb0105","author":"Neogenomics"},{"issue":"2","key":"10.1016\/j.yexmp.2017.06.006_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02484510","article-title":"Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma","volume":"21","author":"Nishikawa","year":"2004","journal-title":"Brain Tumor Pathol."},{"issue":"19","key":"10.1016\/j.yexmp.2017.06.006_bb0115","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1158\/0008-5472.CAN-04-1337","article-title":"Genetic pathways to glioblastoma: a population-based study","volume":"64","author":"Ohgaki","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.yexmp.2017.06.006_bb0120","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The definition of primary and secondary glioblastoma","volume":"19","author":"Ohgaki","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.yexmp.2017.06.006_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10014-011-0029-1","article-title":"Genetic profile of astrocytic and oligodendroglial gliomas","volume":"28","author":"Ohgaki","year":"2011","journal-title":"Brain Tumor Pathol."},{"issue":"12","key":"10.1016\/j.yexmp.2017.06.006_bb0130","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1349-7006.2009.01308.x","article-title":"Genetic alterations and signaling pathways in the evolution of gliomas","volume":"100","author":"Ohgaki","year":"2009","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.yexmp.2017.06.006_bb0135","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","article-title":"Genetic pathways to primary and secondary glioblastoma","volume":"170","author":"Ohgaki","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"Suppl. 2","key":"10.1016\/j.yexmp.2017.06.006_bb0140","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neuro-Oncology"},{"issue":"5897","key":"10.1016\/j.yexmp.2017.06.006_bb0145","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"issue":"40","key":"10.1016\/j.yexmp.2017.06.006_bb2017","article-title":"Neoplasms of the central nervous system: epidemiologic considerations","volume":"22","author":"Percy","year":"1972","journal-title":"Neurol."},{"issue":"12","key":"10.1016\/j.yexmp.2017.06.006_bb0150","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ph6121475","article-title":"Glioblastoma multiforme therapy and mechanisms of resistance","volume":"6","author":"Ramirez","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"10.1016\/j.yexmp.2017.06.006_bb0155","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpneuro0289","article-title":"Epidemiology and molecular pathology of glioma","volume":"2","author":"Schwartzbaum","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.yexmp.2017.06.006_bb0160","doi-asserted-by":"crossref","first-page":"22338","DOI":"10.1038\/srep22338","article-title":"A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma","volume":"6","author":"Shao","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.yexmp.2017.06.006_bb0165","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/humu.22332","article-title":"Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics","volume":"34","author":"Sikkema-Raddatz","year":"2013","journal-title":"Hum. Mutat."},{"issue":"10","key":"10.1016\/j.yexmp.2017.06.006_bb0170","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.yexmp.2017.06.006_bb0175","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.yexmp.2017.06.006_bb0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jocn.2009.09.004","article-title":"Survival comparison between glioblastoma multiforme and other incurable cancers","volume":"17","author":"Tran","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.yexmp.2017.06.006_bb0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ajhg.2009.06.022","article-title":"Massively parallel sequencing: the next big thing in genetic medicine","volume":"85","author":"Tucker","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.yexmp.2017.06.006_bb0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yexcr.2014.01.008","article-title":"Library preparation methods for next-generation sequencing: tone down the bias","volume":"322","author":"van Dijk","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.yexmp.2017.06.006_bb0195","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1158\/1078-0432.CCR-07-1966","article-title":"Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples","volume":"14","author":"Yoshimoto","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.yexmp.2017.06.006_bb0200","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","article-title":"Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression","volume":"94","author":"Weber","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480017301958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480017301958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T13:40:27Z","timestamp":1617457227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480017301958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0014480017301958"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.06.006","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}